Paper41269482
Efficacy of daily silodosin 8 mg as a potential reversible male contraceptive: A prospective placebo controlled study.
Nouh I and 3 others. Int Urol Nephrol, 2026. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Efficacy of daily silodosin 8 mg as a potential reversible male contraceptive: A prospective placebo controlled study. Papers, record 41269482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41269482
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Efficacy of daily silodosin 8 mg as a potential reversible male contraceptive: A prospective placebo controlled study.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Indoles | Major topic |
| Contraceptive Agents, Male | Major topic |
| Humans | |
| Male | |
| Adult | |
| Female | |
| Prospective Studies | |
| Pregnancy | |
| Pregnancy Rate | |
| Young Adult | |
| Sperm Count | |
| Double-Blind Method | |
| Spermatozoa | |
| Semen Analysis |
Source PubMed
References17
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18379048 | Mutational analysis of the alpha 1a-adrenergic receptor binding pocket of antagonists by radioligand binding assay. | Biol Pharm Bull | 2008 | https://conductscience.org/library/papers/18379048 | PubMed |
| 2 | 24297884 | Male contraception via simultaneous knockout of α1A-adrenoceptors and P2X1-purinoceptors in mice. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/24297884 | PubMed |
| 3 | 10224543 | Contraceptive failure rates: new estimates from the 1995 National Survey of Family Growth. | Fam Plann Perspect | 1999 | https://conductscience.org/library/papers/10224543 | PubMed |
| 4 | 29928620 | The future of male contraception: a fertile ground. | Transl Androl Urol | 2018 | https://conductscience.org/library/papers/29928620 | PubMed |
| 5 | 19536124 | Orgasm is preserved regardless of ejaculatory dysfunction with selective alpha1A-blocker administration. | Int J Impot Res | 2009 | https://conductscience.org/library/papers/19536124 | PubMed |
| 6 | 31076850 | A prospective double-blind, randomized, placebo-controlled study to evaluate the efficacy of silodosin 8 mg as an on-demand, reversible, nonhormonal oral contraceptive for males: a pilot study. | World J Urol | 2020 | https://conductscience.org/library/papers/31076850 | PubMed |
| 7 | 23406327 | Which outcome expectancies are important in determining young adults' intentions to use condoms with casual sexual partners?: a cross-sectional study. | BMC Public Health | 2013 | https://conductscience.org/library/papers/23406327 | PubMed |
| 8 | 25951678 | World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. | J Am Coll Dent | 2014 | https://conductscience.org/library/papers/25951678 | PubMed |
| 9 | 32710833 | Unintended pregnancy and abortion by income, region, and the legal status of abortion: estimates from a comprehensive model for 1990-2019. | Lancet Glob Health | 2020 | https://conductscience.org/library/papers/32710833 | PubMed |
| 10 | 1537032 | Chronic testicular pain following vasectomy. | Br J Urol | 1992 | https://conductscience.org/library/papers/1537032 | PubMed |
| 11 | 36404279 | Abortion incidence and service availability in the United States, 2020. | Perspect Sex Reprod Health | 2022 | https://conductscience.org/library/papers/36404279 | PubMed |
| 12 | 6430643 | Phenoxybenzamine--an effective male contraceptive pill. | Contraception | 1984 | https://conductscience.org/library/papers/6430643 | PubMed |
| 13 | 38101934 | Nonhormonal Male Contraceptive Development-Strategies for Progress. | Pharmacol Rev | 2023 | https://conductscience.org/library/papers/38101934 | PubMed |
| 14 | 31692743 | Silodosin Has Nocebo Effect on Sexual Adverse Effects: A Randomized Controlled Trial. | Eurasian J Med | 2019 | https://conductscience.org/library/papers/31692743 | PubMed |
| 15 | 35821454 | The P2X1 receptor as a therapeutic target. | Purinergic Signal | 2022 | https://conductscience.org/library/papers/35821454 | PubMed |
| 16 | 26556545 | Current Contraceptive Use and Variation by Selected Characteristics Among Women Aged 15-44: United States, 2011-2013. | Natl Health Stat Report | 2015 | https://conductscience.org/library/papers/26556545 | PubMed |
| 17 | 21810189 | Investigation of the effects of α1-adrenoceptor antagonism and L-type calcium channel blockade on ejaculation and vas deferens and seminal vesicle contractility in vitro. | J Sex Med | 2012 | https://conductscience.org/library/papers/21810189 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42739649 | Alpha-Adrenoceptor Blockade as a Novel Pathway Toward Non-Hormonal Male Contraception: A Mechanistic and Clinical Evidence Review. | J Clin Med | 2026 | https://conductscience.org/library/papers/42739649 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41269482
GET https://conductscience.org/api/papers/v1/41269482/authors